MS drug may help COVID-19 patients recover faster, study finds

An inhaled version of a drug commonly used to treat multiple sclerosis may help hospitalized COVID-19 patients recover faster, initial study data suggests, according to NBC News.

Interferon is often used in an intravenous form to treat multiple sclerosis. It is naturally released by the body when infected with a virus, and it works by interfering with viral replication. Injectable interferon is approved in the U.S., but an inhaled form is not.